Meet Anna Barker, PhD, Chair of the AACR Scientist↔Survivor Program
In the third post of the “Meet the Chairs” series, Anna Barker, PhD, chair of the AACR Scientist↔Survivor Program...
Category: Meetings
In the third post of the “Meet the Chairs” series, Anna Barker, PhD, chair of the AACR Scientist↔Survivor Program...
In the second post of the "Meet the Chairs" series, Mark Stewart, PhD, chair of the AACR's Associate Member...
In the first post of the "Meet the Chairs" series, Scott Armstrong, MD, PhD, program chair of the 2016...
With the theme of “Shaping the Future of Cancer Prevention: A Roadmap for Integrative Cancer Science and Public Health,”...
Last year saw significant progress against lung cancer, with seven new therapeutics, including two immunotherapeutics, approved by the U.S....
Breast cancer researchers are packed up in San Antonio, eager to build on the latest information they gathered at...
Breast cancer recurrence rates were similar for postmenopausal women with estrogen receptor-positive DCIS whether they took anastrozole or tamoxifen,...
T-DM1, a HER2-targeted antibody-drug conjugate, improved outcomes for patients with HER2-positive, metastatic breast cancer that had progressed despite prior...
Breast-conserving surgery may be a better option than mastectomy for patients with early-stage breast cancer.
Adding denosumab (Xgeva) to adjuvant aromatase inhibitor therapy improved disease-free survival for postmenopausal women with early-stage hormone receptor-positive breast...